drug · small molecule
neflamapimod
Phase 2updated 3mo agoby $CRVO CervoMed Inc.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 6 investigational indications.
indications
indications
Alzheimer's Disease
targets
Mitogen-activated protein kinase 14
all catalysts(0)
nothing on the calendar yet
Trials studying neflamapimod
- phase2Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia
- phase2A Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
- phase2RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
- phase2A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke
- phase2Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 49m ago
Found something off?
comments(0)
5-min edit window · permanent after that